News Related to Oncolytic Virus

Related coverage linked through entity extraction aliases.

Viral Immunotherapy Studies Show Immune Activation in Glioblastoma

May 20, 2026

A phase I trial and a preclinical study found viral immunotherapy triggered T cell responses in glioblastoma. The clinical study enrolled 41 patients; the mouse study showed prolonged survival and immunologic memory.

T-VEC Oncolytic Virus Shows Promise in Breast Cancer and Nonmelanoma Skin Cancer Trials

Feb 23, 2026

Two clinical trials demonstrate efficacy of talimogene laherparepvec (T-VEC) oncolytic virus therapy in HER2-negative breast cancer and nonmelanoma skin cancers, with favorable safety profiles and durable responses in subset of patients.